Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Leaflet VALAROX 10mg / 160mg film-coated tablets
- Product code:
- W63421001
- Quantity:
- 10
- Indicated for:
- dyslipidemia
- Route of administration:
- oral
- Substance:
- rosuvastatin + valsartan (statin lipid-lowering agent + angiotensin II receptor blocker)
- ATC
- C10BX10 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs
Precautions:
Hepatotoxicity
This medicine may affect the liver.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Myopathy / rhabdomyolysis
Seek medical advice if unexplained muscle pain occurs.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
Rosuvastatin+valsartan is a combination medication used for the treatment of dyslipidemia and hypertension. Rosuvastatin is an HMG-CoA reductase inhibitor that lowers LDL cholesterol and triglycerides while increasing HDL cholesterol. Valsartan is an angiotensin II receptor antagonist that helps relax blood vessels and lower blood pressure.
This combination is taken orally, usually once daily, and is indicated for patients requiring both lipid and blood pressure control. It is commonly used to reduce overall cardiovascular risk, including the risk of myocardial infarction and stroke.
Common side effects include headache, dizziness, nausea, and muscle pain. In rare cases, severe adverse reactions such as kidney failure or rhabdomyolysis may occur. Regular monitoring of renal function and lipid profile is essential.
Rosuvastatin+valsartan is an effective therapeutic option for patients at high cardiovascular risk, offering multiple benefits in a single administration.
This combination is taken orally, usually once daily, and is indicated for patients requiring both lipid and blood pressure control. It is commonly used to reduce overall cardiovascular risk, including the risk of myocardial infarction and stroke.
Common side effects include headache, dizziness, nausea, and muscle pain. In rare cases, severe adverse reactions such as kidney failure or rhabdomyolysis may occur. Regular monitoring of renal function and lipid profile is essential.
Rosuvastatin+valsartan is an effective therapeutic option for patients at high cardiovascular risk, offering multiple benefits in a single administration.
General data about VALAROX 10mg / 160mg
- Substance:
- rosuvastatin + valsartan
- Date of latest medicines list:
- 01-06-2017
- Product code:
- W63421001
- Concentration:
- 10mg / 160mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 10
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for rosuvastatin + valsartan
- 10mg/160mg
- 10mg/80mg
- 20mg/160mg
- 20mg/80mg